PAR-23-059 - National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 19

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes NOT-CA-25-035 NCI Jan 17, 2025 Jan 8, 2028 U34, R34, R03, R01, R21, P01
Notice of Special Interest (NOSI): Research on rare cancers across the cancer control continuum NOT-CA-25-010 NCI Dec 30, 2024 Jan 8, 2028 R01, R03, R21, U34, R34, P01
Notice of Special Interest (NOSI): NCI's Interest in Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-25-007 NCI Dec 19, 2024 Jan 8, 2028 R01, UG3/UH3, R03, R21, P01
Notice of Special Interest (NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancers NOT-CA-25-024 NCI Dec 17, 2024 Jan 8, 2028 U34, R34, R01, R03, R21, P01
Notice of Special Interest (NOSI): Communication and Decision-Making in a Complex and Dynamic Cancer Treatment Environment NOT-CA-25-006 NCI Dec 16, 2024 Sep 8, 2028 R01, P01, R21, R03
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health NOT-OD-24-146 OBSSR , NCCIH , NCI , NEI , NHLBI , NIA , NIDA , NIMH , NIMHD , NINR , OAR , ODP , ORWH , SGMRO Jun 24, 2024 Jul 14, 2027 P01, P30, R01, R03, UG3/UH3, R34, U24, R41/R42, R21, R43/R44, R21/R33, R61
Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk NOT-CA-24-037 NCI Mar 7, 2024 May 9, 2026 K08, K22, R01, K99/R00, R21, P01
Notice of Special Interest (NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health Equity NOT-HL-23-110 NHLBI , NCI , NIDCR , NIEHS , NIMH , NIMHD , NINR , OBSSR , ODP , ORWH Nov 28, 2023 Jan 8, 2027 R01, R34, R21, UG3/UH3, K01, R03, P01, P50, K08, K23
Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations NOT-OD-23-166 OD , NCI , NIA , NIAMS , NICHD , NIDDK , NIMH , NIMHD , OBSSR , ODP , ORWH , THRO Aug 28, 2023 May 8, 2026 R21, R15, R01, R34, K25, K99/R00, K01, R03, P01, K08, K23

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes NOT-CA-22-045 NCI Feb 3, 2022 Mar 1, 2024 P01, R21, R01, R03
Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors NOT-CA-22-029 NCI Jan 7, 2022 Oct 9, 2024 R01, R21, P01, R03
Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment NOT-CA-22-014 NCI Dec 8, 2021 Oct 9, 2024 R03, R01, R21, P01
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAID NIAMS NCCIH NCI Nov 23, 2021 Jan 8, 2025 R03, R21, U01, U44, R01, R34, P01, R61/R33
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 NCI NHLBI Nov 4, 2021 Nov 6, 2024 R01, R03, R21, P01
Notice of Special Interest (NOSI): Clinical Characterization and Intervention Strategies for Cancer Therapy Induced Adverse Sequelae NOT-CA-22-005 NCI Oct 28, 2021 May 8, 2023 P01
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas NOT-CA-21-071 NCI Apr 27, 2021 May 8, 2023 P01
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes NOT-CA-21-031 NCI NIA Jan 27, 2021 Jan 8, 2024 R21, R03, R01, U01, P01, K99/R00, K08, R43/R44, R41/R42, R13, R21/R33, K01, K23
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 NCI Apr 9, 2020 May 8, 2023 R03, R21, R01, P01
Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery NOT-CA-20-026 NCI Feb 21, 2020 May 8, 2023 R01, R21, R03, P01
For technical issues E-mail OER Webmaster